Specific excipient requirements in continuous tablet manufacturing
Posted: 29 June 2018 | JRS Pharma | No comments yet
Continuous manufacturing technology continues to gain importance in pharmaceutical manufacturing…
Although traditional processes like direct compression, roller compaction, or wet granulation are used within the continous lines, the requirement for ingredients may differ from traditional batch processing.
This whitepaper analyses the various steps of a continous process in the light of excipient properties.
This evaluation shows that multifunctional excipients such as PROSOLV® SMCC and PROSOLV® EASYtab SP may be particularly well-suited for continuous processes.
The rest of this whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- Modernising drug delivery through gel-based technology
- Webinar: A rational approach to excipient selection for solid dose formulation and development
- Video: High adhesion coating tablet with VIVACOAT® A
- Video: Optimise continuous manufacturing using PROSOLV® EASYtab
- Precision medicine for complex chronic diseases: how near are we?
